T1	intervention 15 42	low-thrombin fibrin sealant
T2	eligibility 669 731	patients undergoing axillary node dissection for breast cancer
T3	total-participants 774 779	Sixty
T5	intervention-participants 860 866	Thirty
T6	control-participants 936 938	30
T7	control 939 953	drainage alone
T12	outcome 1314 1333	Incidence of seroma
T13	outcome 1453 1482	predictor of seroma formation
T14	outcome 1695 1705	lymphedema
T15	iv-bin-percent 1722 1726	6.7%
T16	cv-bin-percent 1730 1733	10%
T20	iv-bin-percent 1639 1641	0%
T21	cv-bin-percent 1645 1650	55.6%
T4	condition 46 118	wound serous drainage, seroma formation and length of postoperative stay
T17	outcome 1569 1575	seroma
T10	outcome 1160 1172	serum output
T11	outcome 1263 1300	length of postoperative hospital stay
T18	iv-cont-mean 1211 1215	94.3
T19	iv-cont-sd 1218 1222	22.4
T22	cv-cont-mean 1226 1229	176
T23	cv-cont-sd 1232 1239	24.6 ml
T24	outcome 1783 1798	amount of fluid
